BLFS BioLife: Bozor kapitallashuvining balans qiymatiga nisbati

BioLife Solutions Inc (BLFS) - korporativ logo

BioLife Solutions, Inc. (BLFS) kompaniyasining 4.52 miqdoridagi bozor qiymati ko'rsatilgan ushbu grafik kompaniyaning biomateriallarni saqlash sektori bo'yicha faoliyatiga asoslangan. Barqaror boshqaruv biznesni hujayralar terapiyasi uchun daromadli komponentlar sari muvaffaqiyatli yo'naltirdi. Geopolitik to'siqlar va tibbiy ma'lumotlarning transchegaraviy uzatilishiga oid murakkabliklarga qaramay, BioLife Solutions, Inc. (BLFS) yordamchi reagentlar va maxsus konteynerlarning barqaror savdosiga tayangan holda samarali kengaymoqda.

BioLife (BLFS): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 18.10.2026gacha

BLFS (BioLife Solutions Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi BioLife Solutions, Inc.|BLFS - Tahlilchilar median maqsadi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi BioLife Corp|BLFS - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar BioLife Solutions|BLFS - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati biolifesolutions.com|BLFS - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati BioLife Solutions, Inc.|BLFS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati BioLife Corp|BLFS - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati BioLife Corp
Fundamental baholash:BioLife Solutions, Inc.
BioLife Solutions Inc ishlab chiqargan mahsulot

Kompaniyaga tegishli kriokonservatsiya yechimlarining yuqori marjali savdolari sof aktiv qiymatida aks etishi kerak bo'lgan barqaror pul oqimini yaratadi. Bozor kapitalizatsiyasining balans qiymatiga nisbatini tahlil qilish orqali investor BioLife Solutions, Inc. (BLFS) haqiqiy kapitalidan yuqori bo'lgan bozor premiumini aniqlaydi, bu esa adolatli past baholanganlikni tizimli biznes pasayishidan ajratish va kapitalni taqsimlash uchun fundamental minimal nuqtani aniq belgilash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Tempus Labs - Bozor qiymatining balans qiymatiga nisbati|qiagen.com (QGEN) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|BEAM - Bozor kapitallashuvining balans qiymatiga nisbati|SRPT - Bozor qiymatining balans qiymatiga nisbati|Twist Bio - Bozor kapitallashuvining balans qiymatiga nisbati|TXG (10x) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati NTLA (Intellia Therapeutics)|Bozor qiymatining balans qiymatiga koeffitsiyenti STOK|Bozor qiymatining balans qiymatiga nisbati Wave Life Sciences Ltd. (WVE)|Bozor qiymatining balans qiymatiga nisbati Maze Therapeutics, Inc. (MAZE)|Bozor kapitallashuvining balans qiymatiga nisbati SION|Balans qiymatiga nisbatan bozor kapitallashuvi Prime Medicine Bio PRME|Bozor kapitallashuvining balans qiymatiga nisbati Taysha Gene Therapies|QURE - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati MGTX|Bozor qiymatining balans qiymatiga koeffitsiyenti REGENXBIO Inc|SLDB - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati OCGN|PACB (Pacific Biosciences) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi BNTC (benitec.com)|DSGN: Bozor qiymatining balans qiymatiga nisbati|Rocket Pharma - Bozor qiymatining balans qiymatiga koeffitsiyenti|FDMT - Bozor qiymatining balans qiymatiga nisbati|Lexeo Therapeutics (LXEO) - Bozor qiymatining balans qiymatiga nisbati|KRRO: Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati editasmedicine.com|Silence Therapeutics plc (SLN) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori ProQR Therapeutics NV|CDXS (Codexis, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SGMO (Sangamo BioSciences)|NAUT: Bozor qiymatining balans qiymatiga nisbati|metagenomi.co - Bozor qiymatining balans qiymatiga koeffitsiyenti|Precision BioSciences (DTIL) - Bozor qiymatining balans qiymatiga nisbati|GBIO: Kapitallashuvning balans qiymatiga nisbati|Boundless Bio, Inc - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Exicure|IMNN - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati RXi Pharmaceuticals|MBIO (Mustang Bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi RNAZ (transcodetherapeutics.com)|BNGO - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Applied DNA Corp APDN|BLUE: Bozor kapitallashuvining balans qiymatiga nisbati|ImmunoPrecise Antibodies (IPA) - Kapitallashuvning sof aktivlarga nisbati|Omega Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|Singular Genomics Systems, Inc. (OMIC) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Regulus Therapeutics Inc|Bozor qiymatining balans qiymatiga nisbati SYRS|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. (TBIO)|Bozor qiymatining balans qiymatiga nisbati traconpharma.com (TCON)|Unity Biotechnology, Inc. (UBX) - Bozor kapitallashuvining balans qiymatiga nisbati